Section of Metabolic Diseases, Beatrix Children's Hospital, University of Groningen, University Medical Center of Groningen, Groningen, The Netherlands.
National Hospital of the Faroe Islands, Medical Center, Tórshavn, Faroe Islands.
J Inherit Metab Dis. 2021 Jan;44(1):226-239. doi: 10.1002/jimd.12302. Epub 2020 Sep 7.
Glycogen storage disease type IIIa (GSDIIIa) is an inborn error of carbohydrate metabolism caused by a debranching enzyme deficiency. A subgroup of GSDIIIa patients develops severe myopathy. The purpose of this study was to investigate whether acute nutritional ketosis (ANK) in response to ketone-ester (KE) ingestion is effective to deliver oxidative substrate to exercising muscle in GSDIIIa patients. This was an investigator-initiated, researcher-blinded, randomized, crossover study in six adult GSDIIIa patients. Prior to exercise subjects ingested a carbohydrate drink (~66 g, CHO) or a ketone-ester (395 mg/kg, KE) + carbohydrate drink (30 g, KE + CHO). Subjects performed 15-minute cycling exercise on an upright ergometer followed by 10-minute supine cycling in a magnetic resonance (MR) scanner at two submaximal workloads (30% and 60% of individual maximum, respectively). Blood metabolites, indirect calorimetry data, and in vivo P-MR spectra from quadriceps muscle were collected during exercise. KE + CHO induced ANK in all six subjects with median peak βHB concentration of 2.6 mmol/L (range: 1.6-3.1). Subjects remained normoglycemic in both study arms, but delta glucose concentration was 2-fold lower in the KE + CHO arm. The respiratory exchange ratio did not increase in the KE + CHO arm when workload was doubled in subjects with overt myopathy. In vivo P MR spectra showed a favorable change in quadriceps energetic state during exercise in the KE + CHO arm compared to CHO in subjects with overt myopathy. Effects of ANK during exercise are phenotype-specific in adult GSDIIIa patients. ANK presents a promising therapy in GSDIIIa patients with a severe myopathic phenotype. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov identifier: NCT03011203.
糖原贮积病 IIIa 型(GSDIIIa)是一种由分支酶缺乏引起的碳水化合物代谢先天性错误。GSDIIIa 患者的亚组会出现严重的肌病。本研究旨在探讨酮酯(KE)摄入引起的急性营养性酮症(ANK)是否能有效地将氧化底物输送到 GSDIIIa 患者的运动肌肉中。这是一项由研究者发起、研究者设盲、随机、交叉的研究,纳入了 6 名成年 GSDIIIa 患者。在运动前,受试者摄入碳水化合物饮料(~66g,CHO)或酮酯(395mg/kg,KE)+碳水化合物饮料(30g,KE+CHO)。受试者在直立式测功仪上进行 15 分钟的自行车运动,然后在磁共振(MR)扫描仪上进行 10 分钟的仰卧自行车运动,两个亚最大工作负荷(分别为个体最大负荷的 30%和 60%)。在运动过程中收集了血液代谢物、间接热量测定数据和股四头肌的体内 P-MR 谱。在所有 6 名受试者中,KE+CHO 诱导产生了中位峰值βHB 浓度为 2.6mmol/L(范围:1.6-3.1)的 ANK。在两种研究臂中,受试者均保持血糖正常,但 KE+CHO 臂中的葡萄糖浓度差值降低了 2 倍。在明显有肌病的受试者中,当工作负荷增加一倍时,KE+CHO 臂中的呼吸交换比并没有增加。与 CHO 相比,在明显有肌病的受试者中,KE+CHO 臂中的股四头肌能量状态在运动过程中表现出有利的变化。ANK 在 GSDIIIa 患者中的作用具有表型特异性。ANK 为 GSDIIIa 患者,尤其是严重肌病表型患者提供了一种很有前途的治疗方法。临床试验注册号:ClinicalTrials.gov 标识符:NCT03011203。